Vor BiopharmaVOR
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$1.62avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was DGS Capital Management, LLC ($90K).
- Company
- Vor Biopharma Inc.
- CUSIP
- 929033207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| DGS Capital Management, LLC | 0.02% | No change | 55,300 | $90K |
"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.